Czechia· CZ-0290559
AREXVY
A respiratorisches-synzytial-virus impfstoffe product containing rsvpref3 (respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation) antigen, registered in Czechia by GlaxoSmithKline Biologicals S.A., Rixensart. The same ATC class is registered in 11 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- RSVPREF3 (RESPIRATORY SYNCYTIAL VIRUS RECOMBINANT GLYCOPROTEIN F STABILISED IN THE PRE-FUSION CONFORMATION) ANTIGEN
- Manufacturer
- GlaxoSmithKline Biologicals S.A., Rixensart
- Country
- Czechia (CZ)
- ATC code
- J07BX05
- ATC class
- Respiratorisches-Synzytial-Virus Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX05
Respiratorisches-synzytial-virus impfstoffe, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e94769b2-113b-4022-b58a-c45f172861aa GET /v1/drugs/e94769b2-113b-4022-b58a-c45f172861aa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ PLS SUS ISP",
"source": "sukl",
"strength": null,
"pack_size": "1+1X0,5ML ISP",
"substance": "RSVPREF3 (RESPIRATORY SYNCYTIAL VIRUS RECOMBINANT GLYCOPROTEIN F STABILISED IN THE PRE-FUSION CONFORMATION) ANTIGEN",
"cz_kod_sukl": "0290559",
"product_type": "IM/BT",
"substance_codes": "2767",
"registration_state": "R",
"registration_number": "EU/1/23/1740/003"
}See everything about respiratorisches-synzytial-virus impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.